SB2413 would change Hawaii’s medical cannabis law in two main ways. First, it would authorize licensed dispensaries to sell viable cannabis seeds to qualifying medical cannabis patients or their primary caregivers, with a cap of no more than 10 seeds per month per patient. The bill defines “viable cannabis seed” and directs the Department of Health to adopt rules to carry out the new seed-sale program.
Second, the bill repeals a provision that allowed the Department of Law Enforcement to inspect a qualifying patient’s medical records held by the certifying provider and to suspend or revoke a provider’s authority to issue medical cannabis certifications if the provider refused inspection or if the records did not comply with the medical cannabis law. The bill also includes standard savings language preserving existing rights, duties, penalties, and proceedings, and it is set to take effect on January 30, 2050.
Impact
The bill would amend Chapter 329D, Hawaii Revised Statutes, to create a new limited intrastate market for viable cannabis seeds for registered medical cannabis patients and their caregivers, while repealing Section 329-123.2 in Chapter 329, which currently gives the Department of Law Enforcement medical-record inspection and enforcement authority over certifying providers. In practical terms, it would shift the regulatory focus toward patient access and away from DLE oversight of provider records, while leaving rulemaking authority with the Department of Health.
Sentiment
The available voting history suggests broad support in committee, with unanimous passage in both the Senate Health and Human Services committee and the Senate Commerce and Consumer Protection committee, each with amendments. The bill’s framing indicates a generally favorable view of improving patient access to seeds and reducing reliance on the illicit market, while also responding to concerns about federal hemp definitions and state restrictions on viable seed sales.
Contention
The main policy tension in SB2413 is between expanding patient access and reducing enforcement oversight. Supporters appear to favor giving medical cannabis patients a lawful local source of seeds for personal cultivation, but the repeal of DLE’s authority to inspect medical records and sanction providers may raise privacy, oversight, and compliance concerns for regulators or those who favor stricter enforcement. Another possible point of concern is the monthly limit of 10 seeds, which reflects an attempt to balance access with control.